Carbamazepine
SIGMA/C4024 - powder
Synonym: 5H-Dibenz[b,f]
CAS Number: 298-46-4
Empirical Formula (Hill Notation): C15H12N2O
Molecular Weight: 236.27
EC Number: 206-062-7
MDL Number: MFCD00005073
Linear Formula: C15H12N2O
Product Type: Chemical
| form | powder |
| InChI | 1S/C15H12N2O/c16-15(18)17 |
| InChI key | FFGPTBGBLSHEPO-UHFFFAOYSA |
| mp | 191-192 °C (lit.) |
| originator | Novartis |
| Quality Level | 100 ![]() |
| SMILES string | NC(=O)N1c2ccccc2C=Cc3cccc |
| solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclode |
| ethanol: soluble | |
| H2O: insoluble | |
| propylene glycol: soluble | |
| storage temp. | 2-8°C |
| Application: | Carbamazepine has been used to investigate its behavior in wastewater treatment and during groundwater infiltration. It has also been used to find out its effects on spontaneous seizures in rats. |
| Biochem/physiol Actions: | Anticonvulsant; ligand for the GABAA receptor benzodiazepine modulatory site. Sodium channel inhibitor. |
| Biochem/physiol Actions: | Carbamazepine is considered as a safe antiepileptic drug. It decreases the multiple drug therapy and maintains a better control of epilepsy. |
| Features and Benefits: | This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5, 10, 25 g in glass bottle |
| Symbol | ![]() GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302 - H317 - H336 - H360D |
| Precautionary statements | P201 - P280 - P301 + P312 + P330 - P302 + P352 - P308 + P313 |
| Hazard Codes | Xn |
| Risk Statements | 22-42/43 |
| Safety Statements | 22-36/37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 2 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| mp | 191-192 °C (lit.) |
| Storage Temp. | 2-8°C |
| UNSPSC | 12352200 |



